Mathematical Models for Early Detection of Relapse in Multiple Myeloma Patients Treated with Bortezomib/ Lenalidomide/Dexamethasone

被引：0
|
作者：
Otani, Yuki [1 ]
Bottino, Dean [2 ]
Gupta, Neeraj [2 ]
Vakilynejad, Majid [2 ]
Tanigawara, Yusuke [3 ]
机构：
[1] Univ Pittsburgh, Dept Anesthesiol & Perioperat Med, Pittsburgh, PA USA
[2] Takeda Dev Ctr Amer Inc TDCA, Lexington, MA USA
[3] Keio Frontier Res & Educ Collaborat Sq K FRECS, Tokyo, Japan
来源：
BLOOD | 2022年 / 140卷
关键词：
DEXAMETHASONE; LENALIDOMIDE;
D O I：
10.1182/blood-2022-157625
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4310 / 4311
页数：2
相关论文
共 50 条
  • [1] MATHEMATICAL MODELS FOR EARLY DETECTION OF RELAPSE IN MULTIPLE MYELOMA PATIENTS TREATED WITH BORTEZOMIB/LENALIDOMIDE/DEXAMETHASONE.
    Otani, Y.
    Bottino, D.
    Gupta, N.
    Vakilynejad, M.
    Tanigawara, Y.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 : S39 - S39
  • [2] Bortezomib, cyclophosphamide, dexamethasone versus lenalidomide, cyclophosphamide, dexamethasone in multiple myeloma patients at first relapse
    Montefusco, Vittorio
    Corso, Alessandro
    Galli, Monica
    Ardoino, Ilaria
    Pezzatti, Sara
    Carniti, Cristina
    Patriarca, Francesca
    Gherlinzoni, Filippo
    Zambello, Renato
    Sammassimo, Simona
    Marcatti, Magda
    Nozza, Andrea
    Crippa, Claudia
    Cafro, Anna Maria
    Baldini, Luca
    Corradini, Paolo
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2020, 188 (06) : 907 - 917
  • [3] Modeling serum M-protein response for early detection of biochemical relapse in myeloma patients treated with bortezomib, lenalidomide and dexamethasone
    Otani, Yuki
    Zhao, Yunqi
    Wang, Guanyu
    Labotka, Richard
    Rogge, Mark
    Gupta, Neeraj
    Vakilynejad, Majid
    Bottino, Dean
    Tanigawara, Yusuke
    [J]. CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2024,
  • [4] DETECTION OF BIOLOGICAL RELAPSE IN PATIENTS WITH MULTIPLE MYELOMA TREATED WITH BORTEZOMIB
    Murillo Florez, I
    Andrade Campos, M.
    Colorado Ledesma, E.
    Espinosa, L. N.
    Tercero, M. M.
    Rupay Rojas, R.
    Giraldo, P.
    [J]. HAEMATOLOGICA, 2015, 100 : 114 - 114
  • [5] Development and Evaluation of Methods for Early Relapse Detection in Multiple Myeloma Patients Treated with Bortezomib
    Bottino, Dean
    Zhao, Yunqi
    Wang, Guanyu
    Gupta, Neeraj
    Yung, Godwin
    Palumbo, Antonio
    Labotka, Richard
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E245 - E245
  • [6] Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
    Sonneveld, Pieter
    Dimopoulos, Meletios A.
    Boccadoro, Mario
    Quach, Hang
    Ho, P. Joy
    Beksac, Meral
    Hulin, Cyrille
    Antonioli, Elisabetta
    Leleu, Xavier
    Mangiacavalli, Silvia
    Perrot, Aurore
    Cavo, Michele
    Belotti, Angelo
    Broijl, Annemiek
    Gay, Francesca
    Mina, Roberto
    Nijhof, Inger S.
    van de Donk, Niels W. C. J.
    Katodritou, Eirini
    Schjesvold, Fredrik
    Sureda Balari, Anna
    Rosinol, Laura
    Delforge, Michel
    Roeloffzen, Wilfried
    Silzle, Tobias
    Vangsted, Annette
    Einsele, Hermann
    Spencer, Andrew
    Hajek, Roman
    Jurczyszyn, Artur
    Lonergan, Sarah
    Ahmadi, Tahamtan
    Liu, Yanfang
    Wang, Jianping
    Vieyra, Diego
    van Brummelen, Emilie M. J.
    Vanquickelberghe, Veronique
    Sitthi-Amorn, Anna
    de Boer, Carla J.
    Carson, Robin
    Rodriguez-Otero, Paula
    Blade, Joan
    Moreau, Philippe
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (04): : 301 - 313
  • [7] A Multicenter Open Label Phase II Study of Pomalidomide, Cyclophosphamide and Dexamethasone in Relapse Multiple Myeloma Patients Initially Treated with Lenalidomide, Bortezomib and Dexamethasone
    Garderet, Laurent
    Kuhnowski, Frederique
    Mary, Jean Yves
    Roussel, Murielle
    Escoffre-Barbe, Martine
    Lafon, Ingrid
    Facon, Thierry
    Karlin, Lionel
    Perrot, Aurore
    Moreau, Philippe
    Marit, Gerald
    Stoppa, Anne-Marie
    Marolleau, Jean-Pierre
    Chaleteix, Carine
    Tiab, Mourad
    Araujo, Carla
    Lenain, Pascal
    Macro, Margaret
    Voog, Eric
    Benboubker, Lofti
    Allangba, Olivier
    Jourdan, Eric
    Mohty, Mohamad
    Loiseau, Herve Avet
    Mathiot, Claire
    Attal, Michel
    [J]. BLOOD, 2017, 130
  • [8] Pomalidomide, bortezomib, and dexamethasone for multiple myeloma previously treated with lenalidomide (OPTIMISMM): outcomes by prior treatment at first relapse
    Meletios Dimopoulos
    Katja Weisel
    Philippe Moreau
    Larry D. Anderson
    Darrell White
    Jesus San-Miguel
    Pieter Sonneveld
    Monika Engelhardt
    Matthew Jenner
    Alessandro Corso
    Jan Dürig
    Michel Pavic
    Morten Salomo
    Eva Casal
    Shankar Srinivasan
    Xin Yu
    Tuong Vi Nguyen
    Tsvetan Biyukov
    Teresa Peluso
    Paul Richardson
    [J]. Leukemia, 2021, 35 : 1722 - 1731
  • [9] Pomalidomide, bortezomib, and dexamethasone for multiple myeloma previously treated with lenalidomide (OPTIMISMM): outcomes by prior treatment at first relapse
    Dimopoulos, Meletios
    Weisel, Katja
    Moreau, Philippe
    Anderson, Larry D., Jr.
    White, Darrell
    San-Miguel, Jesus
    Sonneveld, Pieter
    Engelhardt, Monika
    Jenner, Matthew
    Corso, Alessandro
    Duerig, Jan
    Pavic, Michel
    Salomo, Morten
    Casal, Eva
    Srinivasan, Shankar
    Yu, Xin
    Nguyen, Tuong Vi
    Biyukov, Tsvetan
    Peluso, Teresa
    Richardson, Paul
    [J]. LEUKEMIA, 2021, 35 (06) : 1722 - 1731
  • [10] Upfront bortezomib, lenalidomide, and dexamethasone compared to bortezomib, cyclophosphamide, and dexamethasone in multiple myeloma
    Uttervall, Katarina
    Bruchfeld, Johanna Borg
    Gran, Charlotte
    Walinder, Goran
    Mansson, Robert
    Lund, Johan
    Gahrton, Gosta
    Alici, Evren
    Nahi, Hareth
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 103 (03) : 247 - 254
12345